Key Takeaways BCS has gained 32.3% YTD, outperforming the market and Finance sector, but lagging HSBC and Deutsche Bank. Barclays is cutting costs, selling low-return units and investing in high-growth areas like India. BCS plans 10 billion euros in capital returns from 2024-2026 via dividends and buybacks.Year to date, shares of Barclays PLC (BCS) have risen 32.3%. The stock has outperformed the S&P 500 index, the Zacks Finance sector, and the industry. Meanwhile, it has underperformed its close peer, De ...

Teladoc Health, Inc. (NYSE:TDOC) Goldman Sachs 46th Annual Global Healthcare Conference June 11, 2025 11:30 AM ET Company Participants Charles Divita - CEO & Director Mala Murthy - Chief Financial Officer Conference Call Participants David Harrison Roman - Goldman Sachs Group, Inc., Research Division David Harrison Roman Very pleased to welcome the management team from Teladoc, Chuck Divita, Chief Executive Officer; and Mala Murthy, Chief Financial Officer. Very much appreciate you taking the time to partic ...

GitLab TodayGTLBGitLab$44.12 -4.39 (-9.06%) 52-Week Range$37.90▼$74.18Price Target$65.38Add to WatchlistThere was absolutely nothing wrong with GitLab’s NASDAQ: GTLB Q1 earnings report and guidance. Nothing that is, except a wee bit of tepidness relative to analysts' relatively high bar. The sticking point, the cause for the 12% post-release price plunge, is that the guidance for Q2 revenue and the full year is slightly below the forecasts.  By slight, that means the top end of the range aligns with the co ...

Weight-loss drugs are suppressing appetites for millions of Americans, threatening to upend dining habits at fast-food chains and casting a shadow over the restaurant industry’s long-term growth.The stark warning came from Redburn Atlantic, which on Tuesday issued a rare double downgrade on McDonald's Corp. MCD — cutting the stock from Buy to Sell — amid growing concern that appetite-suppressing medications such as Novo Nordisk A/S’s NVO Wegovy and Eli Lilly and Co.’s LLY Zepbound are reshaping consumer beh ...

Key Takeaways EQNR shares gained 12.5% in 3 months, beating sector and broader market performance. EQNR posted Q1 2025 adjusted income of $8.6B and expects 4% oil and gas output growth for 2025. Equinor plans to launch a power unit in Sept. 2025, combining renewables and trading operations.Shares of Equinor ASA (EQNR) have gained 12.5% in the past six months, outperforming the oil-energy sector and the Zacks S&P 500 composite’s declines of 5.5% and 0.5%, respectively. The company has a market capitalizati ...

Investors in Caleres, Inc. (CAL) need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 17, 2025 $42.50 Call had some of the highest implied volatility of all equity options today.What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mea ...

After a multi-year collapse in its stock price, The Arena Group Holdings (NYSE: AREN ) has been making a strong comeback over the past few months. Trading for under $2 per share two months ago, AREN stock experienced a turbocharged rally from lateAnalyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving ...

Core Viewpoint - The reduction in the U.S. Pentagon's budget request for F-35 fighter jets is not expected to significantly impact Lockheed Martin's stock performance, despite a 5.5% drop in stock price following the news [1][5]. Group 1: Pentagon Budget Changes - The Pentagon has requested 24 F-35 jets for fiscal year 2026, down from the previously forecasted 48 jets, resulting in a $3.5 billion order [3][4]. - An additional $531 million has been requested for parts to build the next batch of F-35s, indicating ongoing production [3]. Group 2: Financial Impact on Lockheed Martin - The $3.5 billion reduction represents only a 5% decrease in expected revenue for Lockheed Martin, which generated $71 billion in business last year [5]. - The majority of the cuts are in orders for F-35A aircraft for the Air Force, with some reductions also affecting Navy F-35Cs and USMC F-35Bs [4]. Group 3: Future Opportunities - Lockheed Martin is positioned for potential contracts worth tens of billions for F-55 and upgraded F-22 aircraft, suggesting a positive outlook for the company despite current budget cuts [6].

Truist Financial Corporation (NYSE:TFC) Morgan Stanley US Financials Conference Call June 11, 2025 9:45 AM ET Company Participants William Henry Rogers - Executive Chairman & CEO Conference Call Participants Betsy Lynn Graseck - Morgan Stanley, Research Division Betsy Lynn Graseck Okay. Thanks, everybody, for joining us this morning. I have to read a disclosure. For important disclosures, please see Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. And if you have any ques ...

Key Takeaways TPIP reduced pulmonary vascular resistance by 35% and improved the six-minute walk distance by 35.5 meters. Insmed plans late-stage PAH trials in early 2026 after FDA talks on study design. TPIP also showed promise in PH-ILD, with plans for late-stage trials starting in H2 2025.Shares of Insmed (INSM) soared nearly 29% yesterday after the company reported positive top-line data from a phase IIb study evaluating its investigational treprostinil palmitil inhalation powder (TPIP) in patients wi ...